One-Pot Three-Component Synthesis of 2,4,5-Triaryl-1H-imidazoles in the Presence of a Molecular Sieve Supported Titanium Catalyst under Mild Basic Conditions

Ágnes Magyar; Zoltán Hell

doi:10.1055/s-0037-1611155

Synlett, Table of Contents

Synlett 2019; 30(01): 89-93
DOI: 10.1055/s-0037-1611155

letter

One-Pot Three-Component Synthesis of 2,4,5-Triaryl-1H-imidazoles in the Presence of a Molecular Sieve Supported Titanium Catalyst under Mild Basic Conditions

Ágnes Magyar

,

Zoltán Hell*

Budapest University of Technology and Economics, Department of Organic Chemistry and Technology, Műegyetem rkp. 3, 1111 Budapest, Hungary Email: magyar.agnes@mail.bme.hu Email: zhell@mail.bme.hu

› Author Affiliations

Abstract

All articles of this category

Abstract

A series of 2,4,5-trisubstituted-imidazoles has been synthesized with good to excellent yields by the one-pot condensation reaction of 1,2-dicarbonyl compounds, benzaldehydes, and ammonium acetate in the presence of 4 Å molecular sieves modified with titanium(IV) as an efficient heterogeneous catalyst. The catalyst could be recovered easily and reused without significant loss of activity.

Keywords

2,4,5-triaryl-1H-imidazoles - multicomponent reactions - titanium - 4 Å molecular sieves - heterogeneous catalysis

Full Text

References

References and Notes
1 Lambardino JG, Wiseman EH. J. Med. Chem. 1974; 17: 1182
2 Philips AP, White HL, Rosen S. EP 58890, 1982
3 Takle AK, Brown MJ. B, Davies S, Dean DK, Francis G, Gaiba A, Hird AW, King FD, Lovell PJ, Naylor A, Reith AD, Steadman JG, Wilson DM. Bioorg. Med. Chem. Lett. 2006; 16: 378
4 de Laszlo SE, Hacker C, Li B, Kim D, MacCoss M, Mantlo N, Pivnichny JV, Colwell L, Koch GE, Cascieri MA, Hagmann WK. Bioorg. Med. Chem. Lett. 1999; 9: 641
5 Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Keys JR, Vatter SW. L, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR. Nature 1994; 372: 739
6 Antolini M, Bozzoli A, Ghiron C, Kennedy G. Bioorg. Med. Chem. Lett. 1999; 9: 1023
7 Heeres J, Backx LJ. J, Mostmans JH, Van Cutsem J. J. Med. Chem. 1979; 22: 1003
8 Khanna IK, Weier RM, Yu Y, Xu XD, Koszyk FJ, Collins PW, Koboldt CM, Veenhuizen AW, Perkins WE, Casler JJ, Masferrer JL, Zhang YY, Gregory SA, Seibert K, Isakson PC. J. Med. Chem. 1997; 40: 1634
9 Wang L, Woods KW, Li Q, Barr KJ, McCroskey RW, Hannick SM, Gherke L, Credo RB, Hui Y.-H, Marsh K, Warner R, Lee JY, Zielinski-Mozng N, Frost D, Rosenberg SH, Sham HL. J. Med. Chem. 2002; 45: 1697
10 Maier T, Schmierer R, Bauer K, Bieringer H, Buerstell H, Sachse B. US 4820335, 1989 ; Chem. Abstr.; 1989, 111: 19494w
11 Schmierer R, Mildenberger H, Buerstell H. DE 361464, 1987 ; Chem. Abstr.; 1988, 108: 37838

For reviews, see:

12a Dupont J, de Souza RF, Suarez PA. Z. Chem. Rev. 2002; 102: 3667
12b Chowdhury S, Mohan RS, Scott JL. Tetrahedron 2007; 63: 2363

For reviews, see:

13a Bourissou D, Guerret O, Gabbai FP, Bertrand G. Chem. Rev. 2000; 100: 39
13b Arnold PL, Liddle ST. Chem. Commun. 2006; 3959
13c Kühl O. Chem. Soc. Rev. 2007; 36: 592

14 Boersma C, Atthobari J, Gansevoort RT, de Jong PE, de Zeeuw D, Annemans LJ, Postma MJ. PharmacoEconomics 2006; 24: 523
15 Abrahams SL, Hazen RJ, Batson AG, Phillips AP. J. Pharmacol. Exp. Ther. 1989; 249: 359
16 Shaabani A, Rahmati A. J. Mol. Catal. A Chem. 2006; 249: 246

17a Wang J, Mason R, VanDerveer D, Feng K, Bu XR. J. Org. Chem. 2003; 68: 5415
17b Puratchikody A, Gopalakrishnan S, Nallu M. Indian J. Pharm. Sci. 2005; 67: 725

18 Safari J, Khalili SD, Banitaba SH. Synth. Commun. 2011; 41: 2359
19 Das Sharma S, Hazarika P, Konwar D. Tetrahedron Lett. 2008; 49: 2216
20 Satyanarayana VS. V, Sivakumar A. Chem. Pap. 2011; 65: 519
21 Shaabani A, Maleki A, Behnam M. Synth. Commun. 2009; 39: 102
22 Siddiqui SA, Narkhede UC, Palimkar SS, Daniel T, Lahoti RJ, Srinivasan KV. Tetrahedron 2005; 61: 3539

23a Wolkenberg SE, Wisnoski DD, Leister WH, Wang Y, Zhao Z, Lindsley CW. Org. Lett. 2004; 6: 1453
23b Bogevig A, Kumaragurubaran N, Juhl K, Zhuang W, Jørgensen KA. Angew. Chem. Int. Ed. 2002; 41: 1790
23c Usyatinsky AY, Khmelnitsky YL. Tetrahedron Lett. 2000; 41: 5031

24a Fodor A, Kiss Á, Debreczeni N, Hell Z, Gresits I. Org. Biomol. Chem. 2010; 8: 4575
24b Magyar Á, Hell Z. Monatsh. Chem. 2016; 147: 1583

25a Magyar Á, Hell Z. Catal. Lett. 2016; 146: 1153
25b Magyar Á, Hell Z. Period. Polytech. Chem. Eng. 2017; 61: 278

26 Magyar Á, Nagy B, Hell Z. Catal. Lett. 2015; 145: 1876
27 Magyar Á, Hell Z. Green Process Synth. 2018; 7: 316
28 ¹H NMR and ¹³C NMR spectra were made on a BRUKER Avance-300 instrument using TMS as an internal standard in DMSO-d₆ . Melting points were determined on SETARAM DSC 92 apparatus, where the initial temperature was 25 °C, followed by programming at 10 °C/min up to 300 °C under nitrogen atmosphere. All compounds and solvents were purchased from Merck Hungary Ltd.
29 The catalyst was prepared according to the method described in ref. 26. Samples were heated at 120 °C for 1 h before the reaction. Figure 1 shows the SEM image of the catalyst. The characteristic cuboctahedron shape of the molecular sieve support can be seen, the particles are well defined both in shape and size, and the titanium is evenly distributed on the surface of the support.
30 General Procedure for the One-Pot Synthesis of 2,4,5-Triaryl-1H-imidazoles A mixture of benzil (1 mmol, 0.21 g), aldehyde (1 mmol), ammonium acetate (2.2 mmol, 0.17 g), and Ti⁴⁺/4A (0.1 g) was stirred in a 10 mL flask at 100 °C. After 1 h toluene (1 mL) was added because the precipitated product impeded stirring of the melt. The stirring was continued, and progress of the reaction was monitored by TLC. After completion (10 h), the mixture was cooled to room temperature, diluted with acetone (10 mL), any solid was filtered off, and the filtrate was evaporated. The product was purified by recrystallization from ethanol.
31 2,4,5-Triphenyl-1H-imidazole (4a) White solid, mp 278 °C (lit.: 274–276 °C²⁰). ¹H NMR (300 MHz): δ = 7.22–7.57 (m, 13 H), 8.09 (d, 2 H), 12.70 (br s, 1 H) ppm. ¹³C NMR (75 MHz): δ = 125.20, 126.53, 127.09, 127.79, 128.20, 128.26, 128.47, 128.69, 130.36, 131.10, 135.19, 137.12, 145.52 ppm. 2-(2-Chlorophenyl)-4,5-diphenyl-1H-imidazole (4b) White solid, mp 197 °C (lit.: 196–198 °C³²). ¹H NMR (300 MHz): δ = 7.28–7.51 (m, 10 H), 7.55 (d, 2 H), 7.61 (t, 1 H), 7.81 (t, 1 H), 12.65 (b rs, 1 H) ppm. ¹³C NMR (75 MHz): δ = 126.51, 127.13, 127.68, 127.99, 128.15, 128.62, 130.01, 130.15, 130.87, 131.48, 131.55, 135.08, 136.86, 143.35 ppm. 2-(4-Chlorophenyl)-4,5-diphenyl-1H-imidazole (4c) White solid, mp 264 °C (lit.: 261–262 °C¹⁹). ¹H NMR (300 MHz): δ = 7.23–7.56 (m, 12 H), 8.11 (d, 2 H), 12.79 (br s, 1 H) ppm. ¹³C NMR (75 MHz): δ = 126.56, 126.80, 127.03, 127.83, 128.16, 128.39, 128.63, 128.73, 129.17, 130.89, 132.71, 134.97, 137.27, 144.38 ppm. 2-(3-Bromophenyl)-4,5-diphenyl-1H-imidazole (4d) White solid, mp 306 °C (lit.: 301–303 °C¹⁸). ¹H NMR (300 MHz): δ = 7.24–7.57 (m, 13 H), 8.10 (d, 1 H), 8.32 (s, 1 H), 12.84 (br s, 1 H) ppm. ¹³C NMR (75 MHz): δ = 121.93, 123.81, 126,49, 126,89, 127.29, 127.71, 128.01, 128.17, 128.45, 130.57, 130.72, 132.27, 134.68, 137.19, 143.64 ppm. 2-(4-Bromophenyl)-4,5-diphenyl-1H-imidazole (4e) White solid, mp 260 °C (lit.: 252–254 °C¹⁶) ppm. ¹H NMR (300 MHz): δ = 7.21–7.53 (m, 10 H), 7.68 (d, 2 H), 8.05 (d, 2 H), 12.83 (br s, 1 H) ppm. ¹³C NMR (75 MHz): δ = 121.90, 126.63, 126.98, 127.62, 127.97, 128.19, 128.69, 129.10, 129.52, 129.71, 130.06, 132.18, 144.99 ppm. 2-(2-Fluorophenyl)-4,5-diphenyl-1H-imidazole (4f) White solid, mp 208 °C (lit.: 205.5–206 °C³³). ¹H NMR (300 MHz): δ = 7.23–7.55 (m, 13 H), 8.00 (t, 1 H), 12.56 (br s, 1 H) ppm. ¹³C NMR (75 MHz): δ = 116.66, 116.82, 119.21, 125.18, 125.21, 127.08, 127.69, 128.33, 128.69, 129.04, 130.14, 130.91, 131.37, 135.49, 137.71, 141.34, 158.35, 160.33 ppm. 4,5-Diphenyl-2-(2-methylphenyl)-1H-imidazole (4g) White solid, mp 253 °C (lit.: 252 °C³³). ¹H NMR (300 MHz): δ = 2.65 (s, 3 H), 7.21 (t, 1 H), 7.29–7.37 (m, 6 H), 7.43 (t, 2 H), 7.52 (d, 2 H), 7.56 (d, 2 H), 7.72 (t, 1 H), 12.49 (br s, 1 H) ppm. ¹³C NMR (75 MHz): δ = 21.63, 126.21, 126.88, 127.52, 127.96, 128.12, 128.67, 128.72, 128.84, 129.13, 129.21, 130.49, 131.59, 135.89, 136.77, 137.11, 146.61 ppm. 4,5-Diphenyl-2-(3-methylphenyl)-1H-imidazole (4h) White solid, mp 299 °C (lit.: 296–298 °C²⁰). ¹H NMR (300 MHz): δ = 2.39 (s, 3 H), 7.20–7.55 (m, 12 H), 7.88 (d, 1 H), 7.94 (s, 1 H), 12.64 (br s, 1 H) ppm. ¹³C NMR (75 MHz): δ = 21.62, 122.88, 126.25, 127.00, 127.58, 128.24, 128.68, 128.92, 129.14, 129.43, 130.03, 130.11, 130.78, 131.61, 135.72, 137.54, 138.31, 146.11 ppm. 4,5-Diphenyl-2-(4-methylphenyl)-1H-imidazole (4i) White solid, mp 239 °C (lit.: 230–233 °C¹⁸). ¹H NMR (300 MHz): δ = 2.35 (s, 3 H), 7.22 (t, 1 H), 7.29 (t, 4 H), 7.37 (t, 1 H), 7.44 (t, 2 H), 7.50 (d, 2 H), 7.56 (d, 2 H), 7.98 (d, 2 H), 12.60 (br s, 1 H) ppm. ¹³C NMR (75 MHz): δ = 21.40, 125.67, 126.95, 127.56, 128.20, 128.43, 128.66, 128.91, 129.13, 129.74, 131.66, 135.76, 137.42, 138.16, 146.16 ppm. 4,5-Diphenyl-2-(3-methoxyphenyl)-1H-imidazole (4k) White solid, mp 266 °C (lit.: 259–262 °C¹⁸). ¹H NMR (300 MHz): δ = 3.84 (s, 3 H), 6.95 (d, 1 H), 7.26–7.57 (m, 11 H), 7.68–7.71 (m, 2 H), 12.70 (br s, 1 H) ppm. ¹³C NMR (300 MHz): δ = 55.72, 110.7, 114.72, 118.13, 127.02, 127.57, 128.31, 128.69, 128.99, 129.16, 130.0, 130.11, 130.31, 131.59, 132.15, 135.64, 136.04, 137.58, 145.86, 160.06 ppm. 4,5-Diphenyl.2-(4-methoxyphenyl)-1H-imidazole (4l) White solid, mp 228.5 °C (lit.: 228–231 °C¹⁸). ¹H NMR (300 MHz): δ = 3.82 (s, 3 H), 7.05 (d, 2 H), 7.21 (t, 1 H), 7.29 (t, 2 H), 7.36 (t, 1 H), 7.44 (t, 2 H), 7.50 (d, 2 H), 7.55 (d, 2 H), 7.79 (s, 2 H), 8.03 (d, 2 H), 12.51 (br s, 1 H) ppm. ¹³C NMR (75 MHz): δ = 55.21, 114.09, 123.14, 126.39, 126.69, 127.04, 127.60, 128.14, 128.35, 128.62, 131.24, 135.33, 136.76, 145.62, 159.41 ppm. 4-(4,5-Diphenyl-1H-imidazol-2-yl)-phenol (4m) Light-yellow solid, mp 214 °C (lit.: 215 °C³⁴). ¹H NMR (300 MHz): δ = 6.94–7.01 (m, 2 H), 7.28 (t, 2 H), 7.30–7.49 (m, 5 H), 7.54 (d, 4 H), 8.06 (d, 1 H), 13.02 (br s, 1 H). ¹³C NMR (75 MHz): δ = 112.88, 116.82, 118.84, 124.94, 128.62, 130.06, 145.87, 156.70 ppm.
32 Shaterian HR, Ranjbar M. J. Mol. Liq. 2011; 160: 40
33 E. I. du Pont de Nemours and Co. Belgian Patent BE 635804, 1963 ; Chem. Abstr.; 1965, 63: 1795
34 Jayabharathi J, Thanikachalam V, Srinivasan N, Jayamorthy K, Perumal MV. J. Fluoresc. 2011; 21: 1813